Product Information
OMEPRAZOLE-BICARB 40-1,680 PKT is a generic product labeled by Strides Pharma Inc., priced at $7.9041 per EA under NDC 64380018302. Its NADAC has been published 146 times since Dec 20, 2023.
FDA first approved this application on Apr 19, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the omeprazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40; 1680 mg/1720mg; mg/1720mg
Manufacturer
Strides Pharma Inc.NDC
64380018302
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OMEPRAZOLE; SODIUM BICARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA079182FDA Approved
4/19/2013
TE Code
AB
On Market Since
10/1/2022
Pharmacological Classes
Price Statistics
The NADAC for OMEPRAZOLE-BICARB 40-1,680 PKT has been published 146 times since Dec 20, 2023, and over the history we have for it it has declined 40.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.9041 per EA |
|---|---|
| All-time high | $18.3077 (Jun 12, 2024) |
| All-time low | $7.9041 (Sep 23, 2026) |
| 52-week high | $10.2732 |
| 52-week low | $7.9041 |
| Median price | $11.5628 |
| Average price | $11.6629 |
| Largest weekly change | +18.7% (Apr 17, 2024) |
| Weeks tracked | 146 |
| Tracking since | Dec 20, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the omeprazole market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
omeprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OMEPRAZOLE-BICARB 40-1,680 PKT?
The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE-BICARB 40-1,680 PKT, manufactured by Strides Pharma Inc., is $7.9041 per EA (NDC 64380018302), effective Sep 30, 2026.
How has the price of OMEPRAZOLE-BICARB 40-1,680 PKT changed over time?
Over the history we have for it, the NADAC for OMEPRAZOLE-BICARB 40-1,680 PKT has declined 40.0%. It has been tracked across 146 weekly CMS publications since Dec 20, 2023.
What are the highest and lowest recorded NADAC prices for OMEPRAZOLE-BICARB 40-1,680 PKT?
Since Dec 20, 2023, the NADAC for OMEPRAZOLE-BICARB 40-1,680 PKT has ranged from a low of $7.9041 (Sep 23, 2026) to a high of $18.3077 (Jun 12, 2024), with a median of $11.5628 per EA.
Are there cheaper alternatives to OMEPRAZOLE-BICARB 40-1,680 PKT?
No other NADAC-published product currently shares the active ingredient and strength of OMEPRAZOLE-BICARB 40-1,680 PKT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OMEPRAZOLE-BICARB 40-1,680 PKT?
OMEPRAZOLE-BICARB 40-1,680 PKT (NDC 64380018302) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.